Thursday, 27 January 2022

Australia's most trusted
source of pharma news

Thursday, 27 January 2022

Big names for HTA Review

Posted 1 December 2021 PM

Medicines Australia has announced the winners of a competitive tender process to be 'lead support' for its much anticipated independent review of Health Technology Assessment to better handle orphan drugs, precision medicine and new technologies.

Shawview Consulting, headed by former MA CEO Brendan Shaw and strategic planning and market research firm Biointelect, founded by Jennifer Herz, will commence work to help get the review underway. 

To see the whole article, please login

Email this article to a friend

Print this article

Copyright Notice

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.

Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.

Welcome to Pharma in Focus

Please log in to read.


Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.


Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).


You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.


You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.